Business
Telescope Reports First Fiscal Quarter 2023 Results
Vancouver, British Columbia--(Newsfile Corp. - February 8, 2023) - Telescope Innovations Corp. (C...
About this update from Telescope Innovations Corp
[{"type":"text","content":"Telescope Reports First Fiscal Quarter 2023 ResultsVancouver, British Columbia--(Newsfile Corp. - February 8, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (\"Telescope\" or the \"Company\"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the first fiscal quarter ended November 30, 2022. The Company also announces its participation in investor events and technical conferences.\"We are pleased to report our second consecutive quarter of revenues. Telescope continues to build our customer base while implementing processes to manage our growth effectively,\" said Dr. Jeffrey Sherman, Chief Operating Officer of Telescope. HIGHLIGHTS OF THE FIRST FISCAL QUARTER OF 2023 ENDED NOVEMBER 30, 2022All values are represented in CAD.Revenues of $511,065Cash on hand of $1,670,343Total assets of $3,796,349Working capital of $1,370,029Net loss of $270,235, or $0.01 per shareFor the complete financial results for the first quarter ended November 30, 2022, readers are encouraged to review the financial statements and accompanying management's discussion and analysis, both of which are available under the profile for the Company on SEDAR (www.sedar.com).INVESTOR EVENTSCalifornia, US | February 6th - 9th 2023 | Investor RoadshowJason Hein (CEO) and Jeff Sherman (COO) are presenting Telescope to investors across 6 cities in California. These focused meetings engage high-net-worth individuals and fund managers specializing in small cap companies.New York | March 20th - 23rd 2023 | Drug, Chemical & Associated Technologies (DCAT) Association WeekTelescope Innovations will participate in a premier global business development event held annually in New York. At DCAT week, innovator companies and generic drug manufacturers meet suppliers of contract research, development, and manufacturing services.CONFERENCES & CLIENT OUTREACHClearwater, FL | March 13th - 15th 2023 | Organic Process Research and Development ConferenceThis industry-leading conference focuses on the conversion of new chemical discoveries into the large-scale commercial manufacturing processes required by the chemical and pharma industries. Telescope Innovations will present our technology response to this challenge by highlighting our automation products and researc...